In the News

May 4, 2020

UCI Mind

Alzheimer’s Disease, Clinical Trials, And COVID-19 With Dr. Daniel Gillen (Video Q&A)

This monthly series features short talks and Q&A with experts from the University of California, Irvine Institute for Memory Impairments and Neurological Disorders (UCI MIND), 1 of 32 congressionally designated Alzheimer’s Disease Research Centers in the nation. Join UCI MIND on Facebook (@UCIrvineMIND) to learn about advances in research to improve Alzheimer’s disease diagnosis, treatment, and prevention.

Watch the video on YouTube.


Alzheimer’s Disease, Clinical Trials, And COVID-19 With Dr. Daniel Gillen (Video Q&A)

< Previous
Why Time Signals Still Matter When Working Remotely
Next >
Professor Roderic Crooks Talks Technology and Racial Inequality in the Context of COVID-19

Media interested in interviewing ICS faculty, students or alumni should contact Matt Miller at (949) 824-1562 or via email at matt.miller@uci.edu.